Nakahata N, Martin M W, Hughes A R, Hepler J R, Harden T K
Mol Pharmacol. 1986 Feb;29(2):188-95.
The H1-histamine receptor antagonist [3H]mepyramine bound with high affinity (Kd = 3-5 nM) to membranes derived from 1321N1 human astrocytoma cells. The H1-receptor antagonists triprolidine and diphenhydramine inhibited [3H]mepyramine binding with Kj values of 1-5 nM, whereas the Kj of the H2-histamine receptor antagonist cimetidine was greater than 100 microM. Histamine also inhibited [3H]mepyramine binding to 1321N1 cell membranes, and the histamine inhibition curve was shifted to the right and steepened in the presence of 1 microM guanosine 5'-O-(3-thiotriphosphate). Treatment of 1321N1 cells with pertussis toxin had no effect on the capacity of histamine to inhibit [3H]mepyramine binding either in the absence or presence of guanosine 5'-O-(3-thiotriphosphate). Therefore, agonist-occupied histamine receptors in these cells apparently interact with a guanine nucleotide regulatory protein that is not the inhibitory guanine nucleotide regulatory protein of adenylate cyclase. Although adenylate cyclase activity was not affected by histamine in a cell-free preparation, incubation of 1321N1 cells with histamine resulted in an attenuation of cyclic AMP accumulation. Analysis of cyclic AMP degradation in the presence of histamine indicated that the effects of histamine on cyclic AMP accumulation are mediated through activation of phosphodiesterase. This idea was supported by the fact that the phosphodiesterase inhibitor 1-isobutyl 3-methylxanthine blocked attenuation of cyclic AMP accumulation by histamine in a noncompetitive manner. Histamine also markedly increased phosphoinositide breakdown and 45Ca2+ efflux in 1321N1 cells. These histamine-induced effects apparently are mediated through H1-receptors, since triprolidine, but not cimetidine, potently inhibited histamine action. As for histamine interaction with its receptor, pertussis toxin had no effect on histamine-induced phosphoinositide breakdown, 45Ca2+ efflux, or attenuation of cyclic AMP accumulation. Taken together, these data indicate that 1321N1 human astrocytoma cells are a useful model system for the study of H1-histamine receptors and the biochemical responses mediated through these receptors.
H1组胺受体拮抗剂[3H]美吡拉敏以高亲和力(Kd = 3 - 5 nM)与源自1321N1人星形细胞瘤细胞的膜结合。H1受体拮抗剂曲普利啶和苯海拉明抑制[3H]美吡拉敏结合,其Kj值为1 - 5 nM,而H2组胺受体拮抗剂西咪替丁的Kj大于100μM。组胺也抑制[3H]美吡拉敏与1321N1细胞膜的结合,并且在存在1μM鸟苷5'-O-(3-硫代三磷酸)的情况下,组胺抑制曲线右移且变陡。用百日咳毒素处理1321N1细胞,无论在不存在还是存在鸟苷5'-O-(3-硫代三磷酸)的情况下,对组胺抑制[3H]美吡拉敏结合的能力均无影响。因此,这些细胞中激动剂占据的组胺受体显然与一种鸟嘌呤核苷酸调节蛋白相互作用,该蛋白不是腺苷酸环化酶的抑制性鸟嘌呤核苷酸调节蛋白。虽然在无细胞制剂中腺苷酸环化酶活性不受组胺影响,但将1321N1细胞与组胺一起孵育会导致环磷酸腺苷(cAMP)积累减弱。在存在组胺的情况下对cAMP降解的分析表明,组胺对cAMP积累的影响是通过磷酸二酯酶的激活介导的。磷酸二酯酶抑制剂1-异丁基-3-甲基黄嘌呤以非竞争性方式阻断组胺对cAMP积累的减弱这一事实支持了这一观点。组胺还显著增加1321N1细胞中的磷脂酰肌醇分解和45Ca2+外流。这些组胺诱导的效应显然是通过H1受体介导的,因为曲普利啶而非西咪替丁能有效抑制组胺的作用。至于组胺与其受体的相互作用,百日咳毒素对组胺诱导的磷脂酰肌醇分解、45Ca2+外流或cAMP积累减弱均无影响。综上所述,这些数据表明1321N1人星形细胞瘤细胞是研究H1组胺受体以及通过这些受体介导的生化反应的有用模型系统。